Amicus shareholders elect four directors, approve 2025 equity plan, ratify EY at annual meeting

AMICUS THERAPEUTICS, INC.

Michael A. Kelly, Margaret G. McGlynn, Michael G. Raab, and Glenn P. Sblendorio elected as Class III directors for three-year terms.
2025 Equity Incentive Plan approved with 253.1M for, 8.9M against, 0.5M abstain.
Ernst & Young LLP ratified as auditor for FY2025 with 277.8M for, 5.0M against.
Advisory say-on-pay approved with 255.8M for, 6.2M against, 0.6M abstain.
Michael G. Raab received 102.5 million withheld votes, indicating significant shareholder dissent.

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.